TRANSLATE 2026: Pioneering Biomedical Innovations

The TRANSLATE 2026 symposium, held by the Manipal Institute of Regenerative Medicine, focused on advancing biomedical research from labs to patient care. Supported by industry leaders, it explored new technologies and collaborations to improve healthcare outcomes, emphasizing interdisciplinary work critical for impactful solutions in medtech and regenerative medicine.

The Manipal Institute of Regenerative Medicine (MIRM) recently hosted TRANSLATE 2026, a symposium dedicated to advancing biomedical research from discovery to patient care. The event attracted scientists, clinicians, and industry leaders keen on exploring new avenues in healthcare innovation.

Key focus areas included advanced biomaterials, regenerative medicine, and bioprinting, aiming to create clinically viable and industry-ready healthcare solutions. The symposium underscored the importance of interdisciplinary collaboration for translating scientific discoveries into practical applications.

Industry experts shared insights on overcoming barriers to commercializing healthcare technologies, with discussions highlighting pathways to foster indigenous innovation and enhance clinical adoption. TRANSLATE 2026 demonstrated MAHE Bengaluru's commitment to pioneering transformational biomedical research in India.